These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 34516556)
21. Metabolomic comparison between cells over-expressing isocitrate dehydrogenase 1 and 2 mutants and the effects of an inhibitor on the metabolism. Wen H; Cho HR; Yun T; Kim H; Park CK; Lee SH; Choi SH; Park S J Neurochem; 2015 Jan; 132(2):183-93. PubMed ID: 25251602 [TBL] [Abstract][Full Text] [Related]
23. Glucose-dependent glucose transporter 1 expression and its impact on viability of thyroid cancer cells. Jóźwiak P; Krześlak A; Bryś M; Lipińska A Oncol Rep; 2015 Feb; 33(2):913-20. PubMed ID: 25502934 [TBL] [Abstract][Full Text] [Related]
24. Metabolic phenotype of bladder cancer. Massari F; Ciccarese C; Santoni M; Iacovelli R; Mazzucchelli R; Piva F; Scarpelli M; Berardi R; Tortora G; Lopez-Beltran A; Cheng L; Montironi R Cancer Treat Rev; 2016 Apr; 45():46-57. PubMed ID: 26975021 [TBL] [Abstract][Full Text] [Related]
28. Sirolimus increases the anti-cancer effect of Huai Er by regulating hypoxia inducible factor-1α-mediated glycolysis in hepatocellular carcinoma. Zhou L; Zhao Y; Pan LC; Wang J; Shi XJ; Du GS; He Q World J Gastroenterol; 2022 Aug; 28(32):4600-4619. PubMed ID: 36157928 [TBL] [Abstract][Full Text] [Related]
30. In silico gene expression analysis reveals glycolysis and acetate anaplerosis in IDH1 wild-type glioma and lactate and glutamate anaplerosis in IDH1-mutated glioma. Khurshed M; Molenaar RJ; Lenting K; Leenders WP; van Noorden CJF Oncotarget; 2017 Jul; 8(30):49165-49177. PubMed ID: 28467784 [TBL] [Abstract][Full Text] [Related]
31. Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism. Reitman ZJ; Yan H J Natl Cancer Inst; 2010 Jul; 102(13):932-41. PubMed ID: 20513808 [TBL] [Abstract][Full Text] [Related]
32. The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway. Carbonneau M; M Gagné L; Lalonde ME; Germain MA; Motorina A; Guiot MC; Secco B; Vincent EE; Tumber A; Hulea L; Bergeman J; Oppermann U; Jones RG; Laplante M; Topisirovic I; Petrecca K; Huot MÉ; Mallette FA Nat Commun; 2016 Sep; 7():12700. PubMed ID: 27624942 [TBL] [Abstract][Full Text] [Related]
33. IDH1 and IDH2 mutations in gliomas and the associated induction of hypoxia-inducible factor and production of 2-hydroxyglutarate. Komotar RJ; Starke RM; Sisti MB; Connolly ES Neurosurgery; 2010 Apr; 66(4):N20-1. PubMed ID: 20305482 [No Abstract] [Full Text] [Related]
34. mTORC1 hyperactivity inhibits serum deprivation-induced apoptosis via increased hexokinase II and GLUT1 expression, sustained Mcl-1 expression, and glycogen synthase kinase 3beta inhibition. Bhaskar PT; Nogueira V; Patra KC; Jeon SM; Park Y; Robey RB; Hay N Mol Cell Biol; 2009 Sep; 29(18):5136-47. PubMed ID: 19620286 [TBL] [Abstract][Full Text] [Related]
35. Mutant IDH1 confers resistance to energy stress in normal biliary cells through PFKP-induced aerobic glycolysis and AMPK activation. Fujiwara H; Tateishi K; Misumi K; Hayashi A; Igarashi K; Kato H; Nakatsuka T; Suzuki N; Yamamoto K; Kudo Y; Hayakawa Y; Nakagawa H; Tanaka Y; Ijichi H; Kogure H; Nakai Y; Isayama H; Hasegawa K; Fukayama M; Soga T; Koike K Sci Rep; 2019 Dec; 9(1):18859. PubMed ID: 31827136 [TBL] [Abstract][Full Text] [Related]
36. TAPP Adaptors Control B Cell Metabolism by Modulating the Phosphatidylinositol 3-Kinase Signaling Pathway: A Novel Regulatory Circuit Preventing Autoimmunity. Jayachandran N; Mejia EM; Sheikholeslami K; Sher AA; Hou S; Hatch GM; Marshall AJ J Immunol; 2018 Jul; 201(2):406-416. PubMed ID: 29884706 [TBL] [Abstract][Full Text] [Related]
37. Ran is a potential therapeutic target for cancer cells with molecular changes associated with activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK pathways. Yuen HF; Chan KK; Grills C; Murray JT; Platt-Higgins A; Eldin OS; O'Byrne K; Janne P; Fennell DA; Johnston PG; Rudland PS; El-Tanani M Clin Cancer Res; 2012 Jan; 18(2):380-91. PubMed ID: 22090358 [TBL] [Abstract][Full Text] [Related]
38. Wogonin reverses hypoxia resistance of human colon cancer HCT116 cells via downregulation of HIF-1α and glycolysis, by inhibiting PI3K/Akt signaling pathway. Wang H; Zhao L; Zhu LT; Wang Y; Pan D; Yao J; You QD; Guo QL Mol Carcinog; 2014 Feb; 53 Suppl 1():E107-18. PubMed ID: 23761018 [TBL] [Abstract][Full Text] [Related]
39. A lentiviral sponge for miRNA-21 diminishes aerobic glycolysis in bladder cancer T24 cells via the PTEN/PI3K/AKT/mTOR axis. Yang X; Cheng Y; Li P; Tao J; Deng X; Zhang X; Gu M; Lu Q; Yin C Tumour Biol; 2015 Jan; 36(1):383-91. PubMed ID: 25266796 [TBL] [Abstract][Full Text] [Related]
40. Isocitrate dehydrogenase 1-mutated human gliomas depend on lactate and glutamate to alleviate metabolic stress. Lenting K; Khurshed M; Peeters TH; van den Heuvel CNAM; van Lith SAM; de Bitter T; Hendriks W; Span PN; Molenaar RJ; Botman D; Verrijp K; Heerschap A; Ter Laan M; Kusters B; van Ewijk A; Huynen MA; van Noorden CJF; Leenders WPJ FASEB J; 2019 Jan; 33(1):557-571. PubMed ID: 30001166 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]